Fitzgerald received her B.Sc. degree in biochemistry in 1995 from University College Cork.[1] She received her Ph.D. in 1999 from Trinity College Dublin,[3] studying with Luke O'Neill.[1] Following her Ph.D., she was postdoc at Trinity College Dublin until 2004 when she moved to the University of Massachusetts Medical School.[4]
Research
Fitzgerald is known for her research in the field of innate immunity and the biology behind inflammatory responses in diseases.[5] She conducts research on many aspects of innate immunity such as the molecular basis of pathogen recognition,[6] the innate immunity to malaria,[7] and the impact with diseases such as lupus or rheumatoid arthritis.[8] In 2021, Fitzgerald published results on an antiviral option to block replication in SARS-CoV-2, the viral agent responsible for COVID-19.[9]
Awards and honors
In 2011, Fitzgerald was a finalist for the Vilcek Prize for Creative Promise in Biomedical Science.[10] In 2015, she was awarded the Science Foundation Ireland (SFI) St. Patrick's Day Science Medal, and she is the first woman to win the award.[11] She has been recognized by Clarivate as a Highly Cited Researcher in the field of immunology by Clarivate every year from 2014 to 2021 for being in the top 1% of authors cited in her field.[12][13] In 2020, she was admitted into the Royal Irish Academy, one of Ireland's most prestigious academic bodies,[14][15] and was elected to the American Academy of Microbiology.[16] In 2021 she was elected to the United States' National Academy of Sciences[17] and the National Academy of Medicine.[18]
^"News from the National Academy of Sciences". 26 April 2021. Retrieved 2 July 2021. Newly elected members and their affiliations at the time of election are: ... Fitzgerald, Katherine A.; professor, department of medicine, and Worcester Foundation for Biomedical Research Chair, University of Massachusetts Medical School, Worcester